UroGen Pharma URGN Earnings Call Transcripts

NASDAQ URGN
$25.32 -0.99 (-3.76%)
As of: Nov 10, 2026 · 3:59 PM EST
9 earnings calls on file for UroGen Pharma, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

UroGen Pharma Q3 2026 Earnings Call

Nov 4, 2026 9,099 words · 40 min read
  • Vincent I. PerroneSenior Director of Investor Relations
  • Elizabeth A. BarrettPresident and Chief Executive Officer
  • Mark SchoenbergChief Medical Officer
  • Christopher DegnanChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

UroGen Pharma Earnings Call Transcripts

Calls9
LatestNov 4, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2020

Fiscal 2019

All 9 UroGen Pharma transcripts Register to get access to UroGen Pharma’s earnings call transcripts.